ArticleJournal of oncology2022

The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma.

Fei Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.